0001570562-20-000049.txt : 20200124
0001570562-20-000049.hdr.sgml : 20200124
20200124211506
ACCESSION NUMBER: 0001570562-20-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200123
FILED AS OF DATE: 20200124
DATE AS OF CHANGE: 20200124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Avelar Rui
CENTRAL INDEX KEY: 0001432063
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 20546945
MAIL ADDRESS:
STREET 1: 1618 STATION STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6A 1B6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
4
1
wf-form4_157991848930412.xml
FORM 4
X0306
4
2020-01-23
0
0001570562
Evolus, Inc.
EOLS
0001432063
Avelar Rui
520 NEWPORT CENTER DR.
SUITE 1200
NEWPORT BEACH
CA
92660
0
1
0
0
See Remarks
Common Stock
2020-01-23
4
A
0
26000
0
A
96802
D
Stock Option (Right to Buy)
10.19
2020-01-23
4
A
0
45000
0
A
2030-01-23
Common Stock
45000.0
45000
D
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
Chief Medical Officer and Head of Research & Development
/s/ Jeffrey J. Plumer, as attorney-in-fact for Rui Avelar
2020-01-24